摘要
目的探讨肉碱棕榈酰转移酶1A(CPT1A)基因多态性与肝细胞癌(HCC)风险的相关性。方法收集2022年3月至2023年3月中国人民解放军空军军医大学第一附属医院收治的HCC患者350例(病例组),选取同期来院体检的健康志愿者350例设为对照组。对两组样本在MassArray平台对rs80356779、rs3019594和rs28461943个单核苷酸多态性(SNP)位点进行基因分型并进行统计分析。结果rs80356779的最小等位基因A与HCC患病风险升高显著相关(P<0.05)。rs80356779和rs3019594位点的基因型频率分布在两组中差异有统计学意义(P<0.05)。rs80356779在显性和加性模型下分别增加了2.17和2.03倍的HCC患病风险(P<0.05),而rs3019594在隐形和加性模型下HCC的患病风险升高1.92和1.36倍(P<0.05)。结论CPT1A基因多态性与HCC患病风险相关,提示rs80356779和rs3019594突变可作为HCC易感人群筛查的潜在位点。
Objective To explore the correlation between carnitine palmitoyl transferase 1A(CPT1A)gene polymorphism and the risk of liver cancer.Methods Three SNPS,rs80356779,rs3019594 and rs2846194,were genotyped and statistically analyzed using MassArray platform in a case-control cohort including 350 patients with hepatocellular carcinoma(HCC)and 350 healthy controls.Results The minimum allele A of rs80356779 was significantly associated with an increased risk of HCC(P<0.05).The genotype frequency distribution of rs80356779 and rs3019594 loci showed statistically significant differences between the two groups(P<0.05).In addition,rs80356779 increased the risk of HCC by 2.17 and 2.03 times in explicit and additive models,respectively(P<0.05),while rs3019594 increased the risk of HCC by 1.92 and 1.36 times in implicit and additive models(P<0.05).Conclusions CPT1A gene polymorphism is correlated with the risk of HCC,suggesting that rs80356779 and rs3019594 mutations can be used as potential screening sites for HCC susceptible populations.
作者
念金梁
马子璐
姜东伯
张溪洋
NIAN Jinliang;MA Zilu;JIANG Dongbo;ZHANG Xiyang(Military Medical Innovation Center of Chinese People's Liberation Army Air Force Military Medical University,Xi'an 710032,Shanxi,China)
出处
《现代实用医学》
2024年第6期719-722,共4页
Modern Practical Medicine
基金
国家自然科学基金(82203733)
陕西省重点研发计划项目(2023-YBSF-273)。
关键词
肝细胞癌
肉碱棕榈酰转移酶1A
单核苷酸多态性
病例-对照研究
相关性分析
Hepatocellular carcinoma
Carnitine palmitoyl transferase 1A
Single nucleotide polymorphism
Case-control study
Association study